Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancer-Reference-Cited by-同舟云学术

Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancer

Published:2022-08 Issue:2 Volume:166 Page:334-343
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Keunecke Carlotta,Kulbe Hagen,Dreher Felix,Taube Eliane T.,Chekerov Radoslav,Horst David,Hummel Michael,Kessler Thomas,Pietzner Klaus,Kassuhn Wanja,Heitz Florian,Muallem Mustafa Z.,Lang Susan M.,Vergote Ignace,Dorigo Oliver,Lammert Hedwig,du Bois Andreas,Angelotti Tim,Fotopoulou Christina,Sehouli Jalid,Braicu Elena I.

Funder

Charité – Universitätsmedizin Berlin

Berlin Institute of Health

Conquer Cancer Foundation

Alexander von Humboldt-Stiftung

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference60 articles.

1. Worldwide Cancer Data;Bray,2018

2. Improved survival in ovarian cancer, with widening survival gaps of races and socioeconomic status: a period analysis, 1983-2012;Wu;J. Cancer,2018